You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Point of care blood coagulopathy diagnostics

    SBC: Coalesenz Inc.            Topic: DHA19A001

    We have developed a novel low-cost, multi-functional blood coagulation sensor that can measure a patient’s coagulation status within less than 10 minutes using a 25mL drop of blood. This device addresses the critical unmet need to identify and manage patients with an elevated risk of life-threatening bleeding or thrombosis, the major causes of in-hospital preventable death. In addition, our inno ...

    STTR Phase II 2020 Department of DefenseDefense Health Agency
  2. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD Research Corporation            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens, whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial and alphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable an ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  3. Cervical Spine Health Improvement Products

    SBC: Switchbox, Inc.            Topic: DHA18B001

    Neck pain is a common and disabling health impairment affecting both military and civilian populations. Due to a lack of objective, reliable, and actionable metrics, occupational interventions and treatment plans are typically based on a trial-and error process that results in suboptimal outcomes and inflated costs. To address this problem, our objective will be to (1) develop an evidence-based te ...

    STTR Phase II 2020 Department of DefenseDefense Health Agency
  4. Marburg Virus Prophylactic Medical Countermeasure

    SBC: MAPP BIOPHARMACEUTICAL, INC.            Topic: CBD18A002

    There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terrible morbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditional vaccines have contributed greatly to public health, they have some limitations especially in the context of operati ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  5. Marburg Virus Prophylactic Medical Countermeasure

    SBC: Flow Pharma, Inc.            Topic: CBD18A002

    Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture the vaccine in a quantity sufficient for the animal studies. In Task 2, we will perform MHC genotyping on a representative population of NHPs and, based on results, select a set of MHC-matched NHPs for ...

    STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense
  6. AeroQUEST II: Aeromedical Quantified Understanding via Experimental Standards Toolkit

    SBC: Aptima, Inc.            Topic: DHA17C001

    Adverse physiological events (PEs) have plagued warfighters piloting military aircraft, particularly incidents involving hypoxia and cockpit cabin decompression. Although a variety of research has been performed to try to understand the problems and root

    STTR Phase II 2019 Department of DefenseDefense Health Agency
  7. Oxygen Production and Delivery on Demand

    SBC: Global Research and Development Inc.            Topic: DHA17B005

    This Phase II proposal is in response to the Defense Health Agency 2017 SBIR topic 17B-005. The approach is an electrochemical membrane oxygen pump using newly developed nano-thickness membrane technology. The total membrane with all the layers is less

    STTR Phase II 2019 Department of DefenseDefense Health Agency
  8. No Power Bionic Lower Extremity Prostheses

    SBC: Liberating Technologies, Inc.            Topic: DHP16C007

    Current prosthetic feet produce much less peak mechanical power than the able-bodied foot/ankle and release only about half of the mechanical energy generated during gait. This leads to higher energy expenditure among amputees as compared to able-bodied i

    STTR Phase II 2019 Department of DefenseDefense Health Agency
  9. Occlusion Effect-Reducing Ear Plug, With Pass-Through Communication

    SBC: Triton Systems, Inc.            Topic: DHA19C001

    Triton Systems proposes to develop easy-to-use in-ear hearing protection which will reduce the occlusion effect, provide pass-through communication and nonlinear filtering of loud sounds.

    STTR Phase I 2020 Department of DefenseDefense Health Agency
  10. Wireless Non-Invasive Advanced Control of Microprocessor Prostheses and Orthoses

    SBC: Liberating Technologies, Inc.            Topic: DHP17A005

    There are several current and imminent orthotic and prosthetic (O&P) fitting scenarios that would greatly benefit from the ability to wirelessly collect and transmit physiological information from the user. Both upper- and lower- limb O&P fittings that: 1) use osseointegration, 2) have cable management issues, and 3) could benefit from physiological information from locations proximal to the prost ...

    STTR Phase II 2018 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government